154 related articles for article (PubMed ID: 36911360)
1. Plasma amyloid beta 40/42, phosphorylated tau 181, and neurofilament light are associated with cognitive impairment and neuropathological changes among World Trade Center responders: A prospective cohort study of exposures and cognitive aging at midlife.
Kritikos M; Diminich ED; Meliker J; Mielke M; Bennett DA; Finch CE; Gandy SE; Carr MA; Yang X; Kotov R; Kuan PF; Bromet EJ; Clouston SAP; Luft BJ
Alzheimers Dement (Amst); 2023; 15(1):e12409. PubMed ID: 36911360
[TBL] [Abstract][Full Text] [Related]
2. Posttraumatic stress disorder and total amyloid burden and amyloid-β 42/40 ratios in plasma: Results from a pilot study of World Trade Center responders.
Clouston SAP; Deri Y; Diminich E; Kew R; Kotov R; Stewart C; Yang X; Gandy S; Sano M; Bromet EJ; Luft BJ
Alzheimers Dement (Amst); 2019 Dec; 11():216-220. PubMed ID: 30859121
[TBL] [Abstract][Full Text] [Related]
3. Pathway Analysis for Plasma β-Amyloid, Tau and Neurofilament Light (ATN) in World Trade Center Responders at Midlife.
Kritikos M; Clouston SAP; Diminich ED; Deri Y; Yang X; Carr M; Gandy S; Sano M; Bromet EJ; Luft BJ
Neurol Ther; 2020 Jun; 9(1):159-171. PubMed ID: 32350803
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease.
Moscoso A; Grothe MJ; Ashton NJ; Karikari TK; Lantero Rodríguez J; Snellman A; Suárez-Calvet M; Blennow K; Zetterberg H; Schöll M;
JAMA Neurol; 2021 Apr; 78(4):396-406. PubMed ID: 33427873
[TBL] [Abstract][Full Text] [Related]
5. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
[TBL] [Abstract][Full Text] [Related]
6. Physical Functional Impairment and the Risk of Incident Mild Cognitive Impairment in an Observational Study of World Trade Center Responders.
Pellecchia A; Kritikos M; Guralnik J; Ahuvia I; Santiago-Michels S; Carr M; Kotov R; Bromet EJ; Clouston SAP; Luft BJ
Neurol Clin Pract; 2022 Dec; 12(6):e162-e171. PubMed ID: 36540142
[TBL] [Abstract][Full Text] [Related]
7. Associations of plasma phosphorylated tau181 and neurofilament light chain with brain amyloid burden and cognition in objectively defined subtle cognitive decline patients.
Huang Y; Li Y; Xie F; Guo Q
CNS Neurosci Ther; 2022 Dec; 28(12):2195-2205. PubMed ID: 36074638
[TBL] [Abstract][Full Text] [Related]
8. Plasma β-amyloid, tau, neurodegeneration biomarkers and inflammatory factors of probable Alzheimer's disease dementia in Chinese individuals.
Sun Q; Ni J; Wei M; Long S; Li T; Fan D; Lu T; Shi J; Tian J
Front Aging Neurosci; 2022; 14():963845. PubMed ID: 36062146
[TBL] [Abstract][Full Text] [Related]
9. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
[TBL] [Abstract][Full Text] [Related]
10. Incidence of mild cognitive impairment in World Trade Center responders: Long-term consequences of re-experiencing the events on 9/11/2001.
Clouston SAP; Diminich ED; Kotov R; Pietrzak RH; Richards M; Spiro A; Deri Y; Carr M; Yang X; Gandy S; Sano M; Bromet EJ; Luft BJ
Alzheimers Dement (Amst); 2019 Dec; 11():628-636. PubMed ID: 31517025
[TBL] [Abstract][Full Text] [Related]
11. Plasma Core Alzheimer's Disease Biomarkers Predict Amyloid Deposition Burden by Positron Emission Tomography in Chinese Individuals with Cognitive Decline.
Ni M; Zhu ZH; Gao F; Dai LB; Lv XY; Wang Q; Zhu XX; Xie JK; Shen Y; Wang SC; Xie Q;
ACS Chem Neurosci; 2023 Jan; 14(1):170-179. PubMed ID: 36547971
[TBL] [Abstract][Full Text] [Related]
12. Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer's disease pathology and clinical disease progression.
Clark C; Lewczuk P; Kornhuber J; Richiardi J; Maréchal B; Karikari TK; Blennow K; Zetterberg H; Popp J
Alzheimers Res Ther; 2021 Mar; 13(1):65. PubMed ID: 33766131
[TBL] [Abstract][Full Text] [Related]
13. Association between polygenic risk score of Alzheimer's disease and plasma phosphorylated tau in individuals from the Alzheimer's Disease Neuroimaging Initiative.
Zettergren A; Lord J; Ashton NJ; Benedet AL; Karikari TK; Lantero Rodriguez J; ; Snellman A; Suárez-Calvet M; Proitsi P; Zetterberg H; Blennow K
Alzheimers Res Ther; 2021 Jan; 13(1):17. PubMed ID: 33419453
[TBL] [Abstract][Full Text] [Related]
14. Microglial Activation, Tau Pathology, and Neurodegeneration Biomarkers Predict Longitudinal Cognitive Decline in Alzheimer's Disease Continuum.
Chen YH; Lin RR; Huang HF; Xue YY; Tao QQ
Front Aging Neurosci; 2022; 14():848180. PubMed ID: 35847667
[TBL] [Abstract][Full Text] [Related]
15. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
[TBL] [Abstract][Full Text] [Related]
16. Risk of Alzheimer's disease is associated with longitudinal changes in plasma biomarkers in the multi-ethnic Washington Heights-Hamilton Heights-Inwood Columbia Aging Project (WHICAP) cohort.
Gu Y; Honig LS; Kang MS; Bahl A; Sanchez D; Reyes-Dumeyer D; Manly JJ; Dage JL; Lantigua RA; Brickman AM; Vardarajan BN; Mayeux R
Alzheimers Dement; 2024 Mar; 20(3):1988-1999. PubMed ID: 38183363
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Alzheimer's Disease Imaging Biomarkers in World Trade Center Responders with Cognitive Impairment at Midlife.
Kritikos M; Franceschi AM; Vaska P; Clouston SAP; Huang C; Salerno M; Deri Y; Tang C; Pellecchia A; Santiago-Michels S; Sano M; Bromet EJ; Lucchini RG; Gandy S; Luft BJ
World J Nucl Med; 2022 Dec; 21(4):267-275. PubMed ID: 36398306
[No Abstract] [Full Text] [Related]
18. Risk of Alzheimer's Disease is Associated with Longitudinal Changes in Plasma Biomarkers in the Multiethnic Washington Heights, Inwood Columbia Aging Project Cohort.
Gu Y; Honig LS; Kang MS; Bahl A; Sanchez D; Reyes-Dumeyer D; Manly JJ; Lantigua RA; Dage JL; Brickman AM; Vardarajan BN; Mayeux R
medRxiv; 2023 Aug; ():. PubMed ID: 37645764
[TBL] [Abstract][Full Text] [Related]
19. Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment.
Giacomucci G; Mazzeo S; Bagnoli S; Ingannato A; Leccese D; Berti V; Padiglioni S; Galdo G; Ferrari C; Sorbi S; Bessi V; Nacmias B
J Neurol; 2022 Aug; 269(8):4270-4280. PubMed ID: 35288777
[TBL] [Abstract][Full Text] [Related]
20. Plasma p-tau
Frank B; Ally M; Brekke B; Zetterberg H; Blennow K; Sugarman MA; Ashton NJ; Karikari TK; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Simkina I; Turk KW; Budson AE; O'Connor MK; Au R; Goldstein LE; Jun GR; Kowall NW; Stein TD; McKee AC; Killiany R; Qiu WQ; Stern RA; Mez J; Alosco ML
Alzheimers Dement; 2022 Aug; 18(8):1523-1536. PubMed ID: 34854549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
